Showing results (121-130 of 156) with videos related to
Sort By:
Pageof 16
Vaccine|February 3, 2026
COVID-19 vaccination during or just prior to pregnancy and hypertensive disorders of pregnancyAndrea J Sharma, Ashley N Smoots, Sabrina A Madni, et al.Vaccine|April 6, 2012
The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnelMark G Thompson, Manjusha J Gaglani, Allison Naleway, et al.Vaccine|January 28, 2014
Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011Nancy A Otieno, Bryan O Nyawanda, Allan Audi, et al.Vaccine|November 13, 2022
Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adultsLindsay K Tompkins, James Baggs, Tanya R Myers, et al.Oncotarget|May 21, 2016
Age, serum 25-hydroxyvitamin D and vitamin D receptor (VDR) expression and function in peripheral blood mononuclear cellsLaura A Coleman, Margarita Mishina, Mark Thompson, et al.Vaccine|May 22, 2012
Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in MaineSamuel B Graitcer, Nancy L Dube, Ricardo Basurto-Davila, et al.Pharmacoepidemiology and Drug Safety|November 7, 2012
Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010Sharon K Greene, Lingling Li, David K Shay, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2016
Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011Fiona Havers, Leslie Sokolow, David K Shay, et al.The Lancet. Infectious Diseases|March 10, 2022
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safeHannah G Rosenblum, Julianne Gee, Ruiling Liu, et al.MMWR. Morbidity and Mortality Weekly Report|August 29, 2025
Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025Danielle L Moulia, Ruth Link-Gelles, Helen Y Chu, et al.Pageof 16